New biomarkers for antibody-drug conjugates in lung cancer the pathologist's perspective.

Saved in:
Bibliographic Details
Title: New biomarkers for antibody-drug conjugates in lung cancer the pathologist's perspective.
Authors: Hofman V; IHU RespirERA, FHU OncoAge, Côte d'Azur University, Laboratory of Clinical and Experimental Pathology, Biobank BB-0033-00025, Pasteur Hospital, Nice, France; IRCAN, Inserm U1081, Faculty of Medicine, Nice, France. Electronic address: hofman.p@ihu-respirera.fr., Rignol G; IHU RespirERA, FHU OncoAge, Côte d'Azur University, Laboratory of Clinical and Experimental Pathology, Biobank BB-0033-00025, Pasteur Hospital, Nice, France; IRCAN, Inserm U1081, Faculty of Medicine, Nice, France., Mograbi B; IHU RespirERA, FHU OncoAge, Côte d'Azur University, Laboratory of Clinical and Experimental Pathology, Biobank BB-0033-00025, Pasteur Hospital, Nice, France; IRCAN, Inserm U1081, Faculty of Medicine, Nice, France., Ilié M; IHU RespirERA, FHU OncoAge, Côte d'Azur University, Laboratory of Clinical and Experimental Pathology, Biobank BB-0033-00025, Pasteur Hospital, Nice, France; IRCAN, Inserm U1081, Faculty of Medicine, Nice, France., Riudavets M; Department of Thoracic Oncology, Hôpital Cochin APHP Centre, Paris, France., Lopez-Rios F; Department of Pathology, Research Institute, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, (imas12), CIBERONC, Madrid, Spain., Fusco N; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Italy., Malapelle U; Department of Public Health, University of Naples Federico II, Naples, Italy., Popat S; Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom., Stenzinger A; Institute of Pathology Heidelberg (IPH), Center for Molecular Pathology, University Hospital Heidelberg and Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, Germany., Planchard D; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Passaro A; Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Milan, Italy., Heeke S; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Peters S; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland., Wistuba II; Department of Translational Molecular Pathology, Moffitt Hospital, Tampa, FL, USA., Hirsch FR; Center for Thoracic Oncology, Tisch Cancer Center, Icahn School of Medicine, Mount Sinai Hospital, NY, USA., Hofman P; IHU RespirERA, FHU OncoAge, Côte d'Azur University, Laboratory of Clinical and Experimental Pathology, Biobank BB-0033-00025, Pasteur Hospital, Nice, France; IRCAN, Inserm U1081, Faculty of Medicine, Nice, France.
Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2026 Aug; Vol. 218, pp. 109507. Date of Electronic Publication: 2026 Jun 23.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1872-8332
DOI:10.1016/j.lungcan.2026.109507